29 December 2021>: Articles
Challenges of Managing Multiple Myeloma Patients with Sickle Cell Disease: A Case Report and Review of Literature
Diagnostic / therapeutic accidents, Educational Purpose (only if useful for a systematic review or synthesis), Rare coexistence of disease or pathology
Maroun Bou Zerdan A , Maria Julia Diacovo E , Chakra P. Chaulagain A*DOI: 10.12659/AJCR.933470
Am J Case Rep 2021; 22:e933470
Table 1. List of reported cases with SCD and MM.
Case | Sex/age | Hb (g/dL) | Hb electrophoresis | Serum M-protein (g/L) | BM PC infiltration |
---|---|---|---|---|---|
1 []3 | M 64 | 13.4 | 44% HbS, 55% HbC, 1% HbF | IgG λ (-) | 15% |
2 []5 | M 65 | 8.6 | 45.8% HbS, 45.2% HbC, 4.6% HbF, 3.1 HbA2 | IgA (17.6) | 80% |
3 []6 | M 58 | 6 | HbSC | IgA κ (46) | 60% |
4 []2 | M 57 | 7.9 | HbS alfa thalassemia | – | – |
5 []4 | F 56 | 7.2 | 10% HbA, 79% HbS, 6% HbF, 5% HbA2 | IgA κ (48) | 90% |
6 []4 | F 57 | 9.7 | 12% HbA, 76% HbS, 8% HbF, 4% HbA2 | IgG κ (70) | 60% |
7 []4 | F 55 | 12.0 | 6% HbA, 79% HbS, 12% HbF, 3% HbA2 | IgG κ (65) | 65% |
8 []4 | M 61 | 10.7 | 12% HbA, 68% HbS, 16% HbF, 4% HbA2 | IgG κ (26) IgA κ (14.7) | 50% |
9 []4 | M 65 | 5.6 | 20% HbA, 74% HbS, 1.6% HbF, 4.2% HbA2 | IgG λ (26.6) | 30% |
10 []4 | F 42 | 7.5 | 88.2% HbS, 10% HbF, 1.8 HbA2 | IgG κ (34) | 35% |
11 []1 | M 35 | 9.9 | 91.4% HbS, 8.6% HbF | IgG κ (48) | – |
Hb – hemoglobin; BM – bone marrow; PC – plasma cell. |